Advertisement
UK markets close in 7 hours 47 minutes
  • FTSE 100

    8,074.86
    +34.48 (+0.43%)
     
  • FTSE 250

    19,605.60
    -113.77 (-0.58%)
     
  • AIM

    753.70
    -0.99 (-0.13%)
     
  • GBP/EUR

    1.1659
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2499
    +0.0037 (+0.30%)
     
  • Bitcoin GBP

    51,209.29
    -2,187.79 (-4.10%)
     
  • CMC Crypto 200

    1,389.71
    +7.14 (+0.52%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     
  • GOLD FUTURES

    2,334.80
    -3.60 (-0.15%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,267.48
    +66.21 (+0.38%)
     
  • DAX

    17,974.95
    -113.75 (-0.63%)
     
  • CAC 40

    8,059.82
    -32.04 (-0.40%)
     

What Analysts Think of Endo International

What Analysts Think of Endo International

Of the 19 analysts covering Endo International (ENDP) stock in July, four of them have given the stock a “buy” or higher rating, 14 have given it a “hold,” and one has given it a “sell.” The mean rating for the stock is 2.74 with a target price of $8.53. Sixteen of the 20 analysts covering Abbott Laboratories (ABT) in July have given the stock a “buy” or higher rating, and four have given it a “hold.” The mean rating for the stock is 1.8 with a target price of $69.